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Abstract
It has been reported that the response to alloantigens presented by the 
direct and indirect pathway may be of differential relevance after human kidney 
transplantation. Accordingly, we monitored these routes in peripheral blood 
mononuclear cells (PBMC) of heart transplant patients from before 
transplantation and up to 2 years thereafter in an attempt to find a correlation 
with the clinical status of the patients.
Both before and after transplantation, comparable proportions of PBMC 
samples reacted in mixed lymphocyte culture to nondepleted donor spleen cells 
(direct route), but never to donor cells depleted for antigen-presenting cells 
(indirect route). In contrast, the latter route could easily be activated by a 
nominal antigen and persisted after transplantation, although the proportion of 
PBMC samples responding was significantly suppressed, irrespective of the 
occurrence of rejection. Consequently, complete removal of antigen-presenting 
cells from the stimulator population in a mixed lymphocyte culture with PBMC as 
responder is not a suitable tool for measuring indirect presentation of 
alloantigens, and therefore not relevant for monitoring the immunological status 
of heart transplant recipients.
The development of alloreactive effector cells participating in allograft 
rejection is dependent on the presence of T helper cells. These T helper cells may 
respond to alloantigens presented by antigen-presenting cells(APC *) via either the 
direct or the indirect pathway(reviewed by Sayegh) (1). The direct presentation 
pathway involves a direct activation of the recipient T cells by donor APC (dAPC). 
For the indirect pathway, donor MHC molecules are internalized by recipient APC
(rAPC), subsequently processed into peptides which are bound by recipient's MHC 
class II molecules, and finally presented at the cell surface of the rAPC to self-MHC-
restricted, allopeptide-specific responder cells. This pathway is identical to the 
presentation of nominal antigens, e.g., tetanus toxoid(TET).
Both presentation pathways were found to be able to induce an alloresponse by 
peripheral blood mononuclear cells (PBMC) of healthy volunteers (2). In renal 
transplant recipients with stable graft function, the direct pathway was not 
different from that of healthy donors, whereas these patients showed no response 
to antigens presented via the indirect pathway. When the latter reactivity was 
detected, a correlation with acute or chronic rejection was reported (3,4). In 
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addition, it was demonstrated that the indirect pathway was more sensitive to 
immunosuppression than the direct route of alloantigen presentation (4,5).
In the present study, we monitored the presence of both antigen presentation 
pathways in PBMC of human cardiac transplant recipients, by measuring the 
proliferative response of their cells to alloantigens in mixed lymphocyte cultures 
(MLC). PBMC were collected longitudinally from the time of transplantation to 2 
years thereafter. The presentation pathways were investigated in an attempt to find 
a correlation with the immunological status of the patients and possibly to obtain a 
relevant tool to monitor the effect of tapering of immunosuppression on the donor-
directed immune response.
PBMC were isolated from heparinized blood by density gradient centrifugation 
using Ficoll-Paque (Pharmacia Biotech AB, Uppsala, Sweden). The PBMC were 
collected from the interphase, washed twice with HBSS (Gibco BRL, Scotland, UK), 
and frozen at -140°C until use. Spleen cells were obtained by mechanical 
dissociation of small pieces of spleen through a sieve of stainless steel in RPMI 1640-
DM supplemented with 4 mM l-glutamine, 100 IU/ml penicillin, 100µg/ml 
streptomycin (all from Gibco, Paisley, Scotland), and 10% pooled heat-inactivated 
human AB serum (i.e., culture medium). DNase (10µg/ml, Boehringer Mannheim 
GmbH, Germany) was added to prevent aggregation of cells. Subsequently, the cell 
suspension was filtrated through a 70-µm cell strainer (Falcon, Franklin Lakes, NJ) 
and washed. Thereafter, the cells were centrifuged over a Ficoll-Paque density 
gradient and stored at-140°C.
To test the response to alloantigens presented via the direct or the indirect 
presentation route, we stimulated PBMC from the transplant recipient with spleen 
cells derived from the heart donor (direct route) or with donor spleen cells depleted 
for dAPC (indirect route). The response to TET (RIVM, Bilthoven, the Netherlands) 
served as positive control for the indirect presentation pathway.
To remove all dAPC, 107 donor spleen cells (in 3.5 ml) were incubated with 125 
µl of anti-CD14 (monocytes/macrophages; MY4, Coulter Immunology, Hialeach, FL), 
75 µl of anti-CD19 (B-cells; Leu-12, Becton Dickinson, San Jose, CA), and 75 µl of 
anti-HLA-DR (dendritic cells; Becton Dickinson) in HBSS and 1% pooled heat-
inactivated human AB serum. After an incubation period of gentle shaking for 30 min 
at 4°C, the cells were washed in HBSS. Thereafter, the cells were incubated with 
210 µl of washed Dynabeads (M-450 sheep anti-mouse IgG, Dynal, Oslo, Norway) for 
30 min of gentle shaking at 4°C. Subsequently, the dAPC were retained by a magnet 
and the nonadherent cells were transported to another tube. This depletion 
procedure was repeated twice before the nonadherent cells were processed further. 
The APC-depleted cells were washed with HBSS and were counted with trypan blue 
to determine the vitality before testing.
For MLC and TET stimulation, 100 µl of a PBMC suspension of 5×105 cells/ml in 
culture medium was added in triplicate wells in a round-bottom 96-well plate 
(Costar, Cambridge, MA) to 100 µl of (a) 5×104 irradiated (60 Gy) spleen cells 
derived from the donor; (b) 5×104 irradiated (60 Gy) dAPC-depleted spleen cells; (c) 
TET at 7.5 lf/ml final concentration; (d) phytohemagglutinin M (1:100 final dilution; 
Difco Laboratories, Detroit, MI) to control the viability of the cells; and(e) culture 
medium. After 6 days of incubation at 37°C in a humidified atmosphere of 5% CO2 in 
air, cell proliferation was measured by incorporation of [3H]thymidine (0.5 µCi/well) 
added during the last 8 hr of culture. The mean counts per minute (cpm) were 
determined and cell proliferation was considered significant when the ratio of the 
cpm obtained in the presence of antigen to the cpm in the absence of antigen was 
higher than 2(stimulation index >2).
The frequency of IL-2-producing T helper lymphocytes (HTL) was determined 
using the limiting dilution analysis assay (slightly modified) of Schanz et al. (6). In 
brief, 24 replicates of graded number PBMC responder cells were titrated in four-
step double dilutions starting from 5×104 to 6250 cells/well and stimulated with 
5×104 irradiated (30 Gy) spleen cells depleted or not depleted for APC. After 3 days 
of culture, 100 µl of the culture supernatant were harvested to test for IL-2 in a 
bioassay using the IL-2-dependent CTLL-2 cell line as indicator system.
The results of the MLC and TET stimulation are shown in Table 1. Most PBMC 
samples taken before heart transplantation (HTx) reacted to both nondepleted 
donor spleen cells (88%) and TET (75%), but never to spleen cells depleted for dAPC. 
Similarly, after HTx, 75% (45/60) of the PBMC samples did respond to spleen cells 
not depleted for dAPC, but not to the depleted population, independent of time 
after transplantation or occurrence of rejection (ISHLT grade 3 or more)(7). In 
Table 1 
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contrast, the response to TET changed both after HTx compared with before HTx, 
and during the posttransplantation follow-up period. During the first year after HTx, 
only 13% (6/47) of the PBMC samples reacted to TET, which is significantly less than 
before HTx(P<0.001). During rejection and nonrejection episodes, no significant 
difference in the TET response was observed (P=0.33). Also, no difference between 
the first and the second year after HTx was found with regard to the TET response 
of samples taken during rejection. In contrast, in periods without rejection, a trend 
was observed in time after HTx, i.e., the TET response was more frequently 
observed during the second year (27%) compared with the first year (9%) after 
transplantation(P=0.15).
These results suggest that later after transplantation the response to nominal 
antigens tends to normalize, possibly as a consequence of the reduction of the 
immunosuppressive load given to the patient. The results obtained with the nominal 
antigen, TET, are in agreement with those found by Shearer's group (4,5), and 
Gallon et al.(8), who demonstrated that T helper cell responses to indirectly 
presented antigens are more sensitive to cyclosporine than responses to direct 
allogeneic stimulation. In contrast to Shearer's group (2-5), who found comparable 
positive responses both to indirectly presented nominal antigens and indirectly 
presented alloantigens in PBMC from kidney transplant recipients and healthy 
controls, we did not find any indirect response to alloantigens. Our results were 
confirmed by an unpublished study of PBMC from healthy persons which did not 
react to an APC-depleted stimulator population in MLC, while positive responses 
were found after stimulation with TET (F.H.J. Claas, Immunohematology and Blood 
Bank, Leiden, personal communication, 1995). Although, the present study was 
different from that of Shearer's group with respect to the organ transplanted and 
the immunosuppressive regimen, we think that the different results are due to the 
different methods used for APC depletion. Depletion of APC by plastic and nylon 
wool adherence may be incomplete, resulting in responses to suboptimal 
concentrations of dAPC, while the response was ascribed to alloantigens indirectly 
presented by rAPC. Dendritic cells are known as very potent APC, inducing MLC 
responses at low stimulator to responder ratios (1 dendritic cell to 1000 T cells)(9). 
Accordingly, a slight contamination of the stimulator population with dendritic cells 
can already induce T cell proliferation in an MLC. The reported correlation of dAPC-
depleted MLC responses with clinical events may rather be associated with the 
presence of a few remaining dAPC in the tests than with the measurement of the 
indirect presentation route. We have checked for the efficiency of the depletion by 
FACS analysis and by performing two-way MLC with two depleted stimulator 
populations. After depletion, 0% CD14+, <1% CD19+, and <1% HLA-DR+ were detected 
by analysis on FACS and in none of the cases was a response found in the two-way 
MLC (stimulation index <=2). From the present study, it is clear that no responses to 
alloantigens in MLC can occur in the absence of dAPC.
An explanation for the positive responses of PBMC to the nondepleted cells and 
the negative responses of PBMC to the dAPC-depleted population, however, remains 
that the direct presentation pathway is responsible for the strong proliferative 
responses seen in vitro by a high frequency of T cell precursors responding to 
allogeneic MHC molecules (10). The MLC used may not be sensitive enough for a 
detectable response to alloantigens presented via the indirect pathway to antigen-
specific T cells that may be present at low frequencies. This was also reported by 
Watschinger et al.(11), who indicated that T cells primed in vivo by a vascularized 
cardiac allograft are able to proliferate in vitro to specific peptides but only when 
presented by APC, which were preincubated with the allopeptide. Therefore, we 
used a limiting dilution analysis assay to determine the HTL frequencies. This assay 
is thought to be more sensitive than MLC to measure responses to directly and 
indirectly presented antigens. We tested 4 pre-HTx samples, because the highest 
responses were expected at that point in time (2). All PBMC reacted clearly to their 
nondepleted donor cell population (57, 33, 77, and 56 HTL/106 cells), while 
responses after APC depletion were nondetectable or very low (6, 0, 17, and 0 
HTL/106 cells, respectively). However, interference of backward stimulation (i.e., 
IL-2 production of stimulator spleen cells in response to PBMC), as described by 
Schanz et al. (6), could have played a role in case of low HTL responses. To avoid 
backward stimulation, generally, B cell lines are used as stimulator cells in the HTL 
assay, but these cell lines are not relevant for monitoring the indirect alloantigen 
presentation pathway, since they are excellent direct stimulators. Accordingly, like 
the MLC, the HTL assay with the APC-depleted cells as stimulator is not usable to 
measure responses of PBMC to indirectly presented alloantigens.
In summary, no difference in response of PBMC to alloantigens presented via 
the direct presentation pathway was detected before or after HTx, irrespective of 
the occurrence of rejection, and a reaction to indirectly presented alloantigens was 
never found. However, the response to TET remained detectable after HTx, 
although in significantly less cases, but again irrespective of rejection. We conclude 
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that monitoring the direct and indirect alloantigen presentation routes in PBMC is 
not useful as a tool for monitoring the immunological status of heart transplant 
recipients.
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